Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy.
ACS Medicinal Chemistry Letters January 9, 2025 DOI: 10.1021/acsmedchemlett.4c00548 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Key findings | AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine. |
Abstract
Artificial intelligence (AI) offers transformative potential in psychedelic research by addressing limitations in personalized treatment, predicting therapeutic outcomes, and understanding complex biological and environmental factors. AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine.
Citations in the library
Cites 4
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Frontiers in Pharmacology January 17, 2018
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Artificial intelligence and psychedelic medicine Annals of the New York Academy of Sciences September 23, 2024
- Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature reviews. Neuroscience June 12, 2013